Lifecome Biochemistry Statistics
Total Valuation
SHE:002868 has a market cap or net worth of CNY 3.67 billion. The enterprise value is 4.14 billion.
Market Cap | 3.67B |
Enterprise Value | 4.14B |
Important Dates
The next estimated earnings date is Friday, August 29, 2025.
Earnings Date | Aug 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SHE:002868 has 155.42 million shares outstanding. The number of shares has increased by 0.98% in one year.
Current Share Class | 155.42M |
Shares Outstanding | 155.42M |
Shares Change (YoY) | +0.98% |
Shares Change (QoQ) | -0.72% |
Owned by Insiders (%) | 37.29% |
Owned by Institutions (%) | 5.01% |
Float | 56.60M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 5.65 |
PB Ratio | -149.49 |
P/TBV Ratio | n/a |
P/FCF Ratio | 224.31 |
P/OCF Ratio | 25.94 |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -9.32 |
EV / Sales | 6.38 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 253.47 |
Financial Position
The company has a current ratio of 0.17
Current Ratio | 0.17 |
Quick Ratio | 0.08 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | 56.01 |
Interest Coverage | -2.47 |
Financial Efficiency
Return on equity (ROE) is -228.96% and return on invested capital (ROIC) is -8.01%.
Return on Equity (ROE) | -228.96% |
Return on Assets (ROA) | -5.54% |
Return on Invested Capital (ROIC) | -8.01% |
Return on Capital Employed (ROCE) | -61.54% |
Revenue Per Employee | 654,610 |
Profits Per Employee | -448,452 |
Employee Count | 992 |
Asset Turnover | 0.38 |
Inventory Turnover | 4.73 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +43.39% in the last 52 weeks. The beta is 0.97, so SHE:002868's price volatility has been similar to the market average.
Beta (5Y) | 0.97 |
52-Week Price Change | +43.39% |
50-Day Moving Average | 18.05 |
200-Day Moving Average | 15.96 |
Relative Strength Index (RSI) | 63.61 |
Average Volume (20 Days) | 3,944,715 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:002868 had revenue of CNY 649.37 million and -444.86 million in losses. Loss per share was -2.86.
Revenue | 649.37M |
Gross Profit | -54.33M |
Operating Income | -153.21M |
Pretax Income | -428.15M |
Net Income | -444.86M |
EBITDA | -56.34M |
EBIT | -153.21M |
Loss Per Share | -2.86 |
Balance Sheet
The company has 24.80 million in cash and 915.81 million in debt, giving a net cash position of -891.01 million or -5.73 per share.
Cash & Cash Equivalents | 24.80M |
Total Debt | 915.81M |
Net Cash | -891.01M |
Net Cash Per Share | -5.73 |
Equity (Book Value) | -24.54M |
Book Value Per Share | -0.17 |
Working Capital | -1.03B |
Cash Flow
In the last 12 months, operating cash flow was 141.41 million and capital expenditures -125.06 million, giving a free cash flow of 16.35 million.
Operating Cash Flow | 141.41M |
Capital Expenditures | -125.06M |
Free Cash Flow | 16.35M |
FCF Per Share | 0.11 |
Margins
Gross margin is -8.37%, with operating and profit margins of -23.59% and -68.51%.
Gross Margin | -8.37% |
Operating Margin | -23.59% |
Pretax Margin | -65.93% |
Profit Margin | -68.51% |
EBITDA Margin | -8.68% |
EBIT Margin | -23.59% |
FCF Margin | 2.52% |
Dividends & Yields
SHE:002868 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.98% |
Shareholder Yield | n/a |
Earnings Yield | -12.13% |
FCF Yield | 0.45% |
Stock Splits
The last stock split was on May 28, 2020. It was a forward split with a ratio of 1.3.
Last Split Date | May 28, 2020 |
Split Type | Forward |
Split Ratio | 1.3 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |